These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6348513)

  • 1. Induction of fibrin-specific antibodies by immunization with synthetic peptides that correspond to amino termini of thrombin cleavage sites.
    Pacella BL; Hui KY; Haber E; Matsueda GR
    Mol Immunol; 1983 May; 20(5):521-7. PubMed ID: 6348513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies of predetermined specificity for fibrin: a rational approach to monoclonal antibody production.
    Hui KY; Haber E; Matsueda GR
    Hybridoma; 1986; 5(3):215-22. PubMed ID: 2429911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide.
    Scheefers-Borchel U; Müller-Berghaus G; Fuhge P; Eberle R; Heimburger N
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7091-5. PubMed ID: 2413458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin.
    Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
    Mol Immunol; 1983 Nov; 20(11):1191-200. PubMed ID: 6656769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes.
    Bilezikian SB; Nossel HL; Butler VP; Canfield RE
    J Clin Invest; 1975 Aug; 56(2):438-45. PubMed ID: 50328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of synthetic peptides to produce a variety of fibrin antibodies.
    McCallion D; Stirk CM; McNally S; Thompson WD; Melvin WT
    Biochem Soc Trans; 1996 May; 24(2):285S. PubMed ID: 8736943
    [No Abstract]   [Full Text] [Related]  

  • 7. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma.
    Soe G; Kohno I; Inuzuka K; Itoh Y; Matsuda M
    Blood; 1996 Sep; 88(6):2109-17. PubMed ID: 8822930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of the complete coding sequence of rat fibrinogen B beta chain cDNA: interspecies conservation of fibrin beta 15-42 primary structure.
    Courtney MA; Bunce LA; Neroni LA; Simpson-Haidaris PJ
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):487-96. PubMed ID: 7841303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies formed against fibrin glue components and their circulatory relevance.
    Seifert J; Klause N; Stobbe J; Egbers HJ
    J Invest Surg; 1994; 7(2):167-71. PubMed ID: 8049180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
    Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
    Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amino acids that constitute sequence gamma 268-282 of fibrinogen are not involved in fibrin monomer polymerization.
    Janiak A; Plucinski T; Kupryszewski G; Cierniewski CS
    Acta Biochim Pol; 1993; 40(4):515-20. PubMed ID: 8140826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a monoclonal antibody specific to the amino terminus of the alpha-chain of human fibrin.
    Mao SJ; Rechtin AE; Krstenansky JL; Jackson RL
    Thromb Haemost; 1990 Jun; 63(3):445-8. PubMed ID: 2402748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies distinguish synthetic peptides that differ in one chemical group.
    Motté P; Alberici G; Ait-Abdellah M; Bellet D
    J Immunol; 1987 May; 138(10):3332-8. PubMed ID: 2437187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of fibrin network ultrastructure by Fab fragments specific for different domain of fibrinogen.
    Cierniewski CS; Janiak A; Wyroba E
    Acta Biochim Pol; 1986; 33(3):195-202. PubMed ID: 2433859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the species selectivity of a fibrin-specific monoclonal antibody.
    Matsueda GR; Margolies MN
    Biochemistry; 1986 Mar; 25(6):1451-5. PubMed ID: 2421767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymerization site in the beta chain of fibrin: mapping of the B beta 1-55 sequence.
    Pandya BV; Gabriel JL; O'Brien J; Budzynski AZ
    Biochemistry; 1991 Jan; 30(1):162-8. PubMed ID: 1988018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of antisera using peptide conjugates.
    Adrian TE
    Methods Mol Biol; 1997; 73():239-49. PubMed ID: 9031212
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic assessment of patients treated with bovine fibrin as a hemostatic agent.
    Carroll JF; Moskowitz KA; Edwards NM; Hickey TJ; Rose EA; Budzynski AZ
    Thromb Haemost; 1996 Dec; 76(6):925-31. PubMed ID: 8972012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte suppressive peptides from fibrinogen are derived predominantly from the A alpha chain.
    Plow EF; Edgington TS
    J Immunol; 1986 Sep; 137(6):1910-5. PubMed ID: 2943807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of heterologous antibodies specific for murine B-cell leukemia (BCL1) immunoglobulin by immunization with synthetic peptides homologous to heavy chain hypervariable regions.
    Smith LJ; Maloy WL; Braylan RC; Wakeland EK
    Cancer Res; 1985 Dec; 45(12 Pt 1):6119-23. PubMed ID: 3933821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.